HMO is a professional service provider of global scientific research chemicals and biologically active compounds. HMO's product range covers various inhibitors, agonists, compound libraries and biological antibodies. Committed to providing global customers with novel and complete high-quality small molecule active compounds. More than 30,000 specific inhibitors and agonists act on all target proteins in all signaling pathways such as epigenetics, PI3K/Akt/mTOR, apoptosis, MAPK, Wnt, etc., covering popular diseases such as cancer, neuroscience, and immunology Research areas.